Get access

Cyclic bisphosphonate therapy in osteogenesis imperfecta type V

Authors


Professor David O. Sillence, Academic Department of Medical Genetics, The Children's Hospital at Westmead, Sydney, NSW 2145, Australia. Fax: + 61 02 9845 3204; email: davids@chw.edu.au

Abstract

Abstract:  The clinical and radiographic features and management of a young person with recently delineated Osteogenesis Imperfecta Type V is described. A female aged 9 years presented with a history of multiple fractures since 3 years of age and bilateral dislocation of the elbows from infancy. She was commenced on a low dose frequent regimen of cyclic intravenous pamidronate, which resulted in progressive improvement in bone density, reduced fracture frequency and remission of symptoms of osteoporosis.

Get access to the full text of this article

Ancillary